{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:26:56Z","timestamp":1777879616718,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>Many patients maintained on depot medication have raised prolactin levels, which can lead to a range of long-term medical problems. The addition of aripiprazole can reduce prolactin levels and restore sexual function in these patients. The cases described demonstrate the potential role of aripiprazole in a forensic setting.<\/jats:p>","DOI":"10.1177\/2045125311409284","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T20:54:32Z","timestamp":1306875272000},"page":"77-79","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Aripiprazole use combined with depot antipsychotic medication: two cases demonstrating its ability to reduce prolactin levels in an adolescent forensic hospital"],"prefix":"10.1177","volume":"1","author":[{"given":"Simon A.","family":"Hill","sequence":"first","affiliation":[{"name":"Consultant Forensic Psychiatrist, Bluebird House, Tatchbury Mount, Calmore, Southampton SO40 2RZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al Aditya","family":"Khan","sequence":"additional","affiliation":[{"name":"Speciality Registrar (ST6) in Forensic Psychiatry, Bluebird House, Tatchbury Mount, Calmore, Southampton SO40 2RZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Wetherill","sequence":"additional","affiliation":[{"name":"Locality Lead Pharmacist, Bluebird House, Tatchbury Mount, Calmore, Southampton SO40 2RZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"bibr1-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00996.x"},{"key":"bibr2-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511543593.017"},{"key":"bibr3-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.195.52.s37"},{"key":"bibr4-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1007\/BF02238717"},{"key":"bibr5-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02562.x"},{"key":"bibr6-2045125311409284","doi-asserted-by":"crossref","unstructured":"Finn, S.E., Bailey, J.M., Schultz, R.T., Faber, R. (1990) Subjective utility ratings of neuroleptics in treating schizophrenia.\n                      Psychological Medicine\n                      20: 843\u2013848.","DOI":"10.1017\/S0033291700036539"},{"key":"bibr7-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00112-9"},{"key":"bibr8-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31819a8dbe"},{"key":"bibr9-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.4.317"},{"key":"bibr10-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e318123ee01"},{"key":"bibr11-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.108.024257"},{"key":"bibr12-2045125311409284","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"Lehman A.F.","year":"2004","journal-title":"Am J Psychiatry"},{"key":"bibr13-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31814f4d5d"},{"issue":"4","key":"bibr14-2045125311409284","first-page":"56","volume":"63","author":"Maguire G.A.","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"bibr15-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00050-1"},{"key":"bibr16-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1007\/s004060170049"},{"key":"bibr17-2045125311409284","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1115"},{"key":"bibr18-2045125311409284","first-page":"82","author":"National Institute for Health and Clinical Excellence","year":"2009","journal-title":"in the treatment and management of schizophrenia in adults in primary and secondary care (update). NICE Clinical Guideline"},{"key":"bibr19-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00158-3"},{"key":"bibr20-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071075"},{"key":"bibr21-2045125311409284","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.109.027086"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125311409284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125311409284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:48:50Z","timestamp":1777592930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2045125311409284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1177\/2045125311409284"],"URL":"https:\/\/doi.org\/10.1177\/2045125311409284","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}